Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,196 public trials 262 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

NCT07480356

Conditions
Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Carcinoma in Situ, +16 more
Locations
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Michael Oefelein Clinical Trials Bakersfield, California, United States
  • Renown Regional Medical Center St Louis, Missouri, United States
View Trial Details
Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

NCT07225127

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions
Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations
  • Mercy Hospital - FTS Fort Smith, Arkansas, United States
  • Frederick Health Hospital Frederick, Maryland, United States
  • Mercy Hospital - SPG Springfield, Missouri, United States
  • Mercy Hospital - South St Louis, Missouri, United States
View Trial Details
Recruiting

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

NCT07232602

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • UCSF Medical Center at Mission Bay ( Site 5044) San Francisco, California, United States
  • University of Chicago Medical Center ( Site 5037) Chicago, Illinois, United States
  • Cleveland Clinic Taussig Cancer ( Site 5036) Cleveland, Ohio, United States
  • Huntsman Cancer Institute ( Site 5041) Salt Lake City, Utah, United States
View all 16 locations
View Trial Details
Recruiting

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

NCT05312671

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Johns Hopkins University: Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT04752722

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
Locations
  • The University of Alabama at Birmingham Clinical Research Unit (CRU) Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Urological Associates of South Arizona Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 102 locations
View Trial Details
Recruiting

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

NCT05614739

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology Los Angeles, California, United States
  • University of California - Irvine Orange, California, United States
View all 82 locations
View Trial Details

Related conditions